nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000987	0.000987	CcSEcCtD
Tramadol—Tremor—Carmustine—lymphatic system cancer	0.000984	0.000984	CcSEcCtD
Tramadol—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000982	0.000982	CcSEcCtD
Tramadol—Erythema—Mitoxantrone—lymphatic system cancer	0.000976	0.000976	CcSEcCtD
Tramadol—Infection—Bleomycin—lymphatic system cancer	0.000976	0.000976	CcSEcCtD
Tramadol—Anaemia—Carmustine—lymphatic system cancer	0.000971	0.000971	CcSEcCtD
Tramadol—Back pain—Vincristine—lymphatic system cancer	0.00097	0.00097	CcSEcCtD
Tramadol—Vomiting—Teniposide—lymphatic system cancer	0.000969	0.000969	CcSEcCtD
Tramadol—Agitation—Carmustine—lymphatic system cancer	0.000965	0.000965	CcSEcCtD
Tramadol—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000961	0.000961	CcSEcCtD
Tramadol—Asthenia—Fludarabine—lymphatic system cancer	0.000961	0.000961	CcSEcCtD
Tramadol—Rash—Teniposide—lymphatic system cancer	0.000961	0.000961	CcSEcCtD
Tramadol—Dermatitis—Teniposide—lymphatic system cancer	0.00096	0.00096	CcSEcCtD
Tramadol—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000956	0.000956	CcSEcCtD
Tramadol—Headache—Teniposide—lymphatic system cancer	0.000955	0.000955	CcSEcCtD
Tramadol—Pruritus—Fludarabine—lymphatic system cancer	0.000948	0.000948	CcSEcCtD
Tramadol—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000947	0.000947	CcSEcCtD
Tramadol—Back pain—Mitoxantrone—lymphatic system cancer	0.000944	0.000944	CcSEcCtD
Tramadol—Anorexia—Bleomycin—lymphatic system cancer	0.000936	0.000936	CcSEcCtD
Tramadol—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000929	0.000929	CcSEcCtD
Tramadol—Anaemia—Vincristine—lymphatic system cancer	0.000927	0.000927	CcSEcCtD
Tramadol—Agitation—Vincristine—lymphatic system cancer	0.000921	0.000921	CcSEcCtD
Tramadol—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00092	0.00092	CcSEcCtD
Tramadol—Photosensitivity—Methotrexate—lymphatic system cancer	0.00092	0.00092	CcSEcCtD
Tramadol—Polyuria—Methotrexate—lymphatic system cancer	0.00092	0.00092	CcSEcCtD
Tramadol—Hypotension—Bleomycin—lymphatic system cancer	0.000918	0.000918	CcSEcCtD
Tramadol—Diarrhoea—Fludarabine—lymphatic system cancer	0.000916	0.000916	CcSEcCtD
Tramadol—Convulsion—Carmustine—lymphatic system cancer	0.00091	0.00091	CcSEcCtD
Tramadol—Hypertension—Carmustine—lymphatic system cancer	0.000907	0.000907	CcSEcCtD
Tramadol—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000906	0.000906	CcSEcCtD
Tramadol—Nausea—Teniposide—lymphatic system cancer	0.000905	0.000905	CcSEcCtD
Tramadol—Anaemia—Mitoxantrone—lymphatic system cancer	0.000902	0.000902	CcSEcCtD
Tramadol—Vertigo—Vincristine—lymphatic system cancer	0.000901	0.000901	CcSEcCtD
Tramadol—Hepatic failure—Methotrexate—lymphatic system cancer	0.000899	0.000899	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000895	0.000895	CcSEcCtD
Tramadol—Chest pain—Carmustine—lymphatic system cancer	0.000894	0.000894	CcSEcCtD
Tramadol—Myalgia—Carmustine—lymphatic system cancer	0.000894	0.000894	CcSEcCtD
Tramadol—Anxiety—Carmustine—lymphatic system cancer	0.000891	0.000891	CcSEcCtD
Tramadol—Paraesthesia—Bleomycin—lymphatic system cancer	0.000882	0.000882	CcSEcCtD
Tramadol—Malaise—Mitoxantrone—lymphatic system cancer	0.000881	0.000881	CcSEcCtD
Tramadol—Dyspnoea—Bleomycin—lymphatic system cancer	0.000875	0.000875	CcSEcCtD
Tramadol—Convulsion—Vincristine—lymphatic system cancer	0.000869	0.000869	CcSEcCtD
Tramadol—Hypertension—Vincristine—lymphatic system cancer	0.000866	0.000866	CcSEcCtD
Tramadol—Confusional state—Carmustine—lymphatic system cancer	0.000864	0.000864	CcSEcCtD
Tramadol—Decreased appetite—Bleomycin—lymphatic system cancer	0.000854	0.000854	CcSEcCtD
Tramadol—Myalgia—Vincristine—lymphatic system cancer	0.000854	0.000854	CcSEcCtD
Tramadol—Visual disturbance—Methotrexate—lymphatic system cancer	0.000852	0.000852	CcSEcCtD
Tramadol—Cough—Mitoxantrone—lymphatic system cancer	0.000852	0.000852	CcSEcCtD
Tramadol—Infection—Carmustine—lymphatic system cancer	0.000852	0.000852	CcSEcCtD
Tramadol—Vomiting—Fludarabine—lymphatic system cancer	0.000852	0.000852	CcSEcCtD
Tramadol—Convulsion—Mitoxantrone—lymphatic system cancer	0.000846	0.000846	CcSEcCtD
Tramadol—Rash—Fludarabine—lymphatic system cancer	0.000844	0.000844	CcSEcCtD
Tramadol—Dermatitis—Fludarabine—lymphatic system cancer	0.000844	0.000844	CcSEcCtD
Tramadol—Hypertension—Mitoxantrone—lymphatic system cancer	0.000843	0.000843	CcSEcCtD
Tramadol—Pain—Bleomycin—lymphatic system cancer	0.00084	0.00084	CcSEcCtD
Tramadol—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000839	0.000839	CcSEcCtD
Tramadol—Headache—Fludarabine—lymphatic system cancer	0.000839	0.000839	CcSEcCtD
Tramadol—Tachycardia—Carmustine—lymphatic system cancer	0.000837	0.000837	CcSEcCtD
Tramadol—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000831	0.000831	CcSEcCtD
Tramadol—Chest pain—Mitoxantrone—lymphatic system cancer	0.000831	0.000831	CcSEcCtD
Tramadol—Myalgia—Mitoxantrone—lymphatic system cancer	0.000831	0.000831	CcSEcCtD
Tramadol—Anxiety—Mitoxantrone—lymphatic system cancer	0.000828	0.000828	CcSEcCtD
Tramadol—Lethargy—Methotrexate—lymphatic system cancer	0.000824	0.000824	CcSEcCtD
Tramadol—Discomfort—Mitoxantrone—lymphatic system cancer	0.000821	0.000821	CcSEcCtD
Tramadol—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000818	0.000818	CcSEcCtD
Tramadol—Anorexia—Carmustine—lymphatic system cancer	0.000817	0.000817	CcSEcCtD
Tramadol—Infection—Vincristine—lymphatic system cancer	0.000813	0.000813	CcSEcCtD
Tramadol—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000809	0.000809	CcSEcCtD
Tramadol—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000808	0.000808	CcSEcCtD
Tramadol—Confusional state—Mitoxantrone—lymphatic system cancer	0.000804	0.000804	CcSEcCtD
Tramadol—Nervous system disorder—Vincristine—lymphatic system cancer	0.000802	0.000802	CcSEcCtD
Tramadol—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000801	0.000801	CcSEcCtD
Tramadol—Hypotension—Carmustine—lymphatic system cancer	0.000801	0.000801	CcSEcCtD
Tramadol—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000797	0.000797	CcSEcCtD
Tramadol—Nausea—Fludarabine—lymphatic system cancer	0.000796	0.000796	CcSEcCtD
Tramadol—Infection—Mitoxantrone—lymphatic system cancer	0.000792	0.000792	CcSEcCtD
Tramadol—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000791	0.000791	CcSEcCtD
Tramadol—Shock—Mitoxantrone—lymphatic system cancer	0.000784	0.000784	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000781	0.000781	CcSEcCtD
Tramadol—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00078	0.00078	CcSEcCtD
Tramadol—Urticaria—Bleomycin—lymphatic system cancer	0.00078	0.00078	CcSEcCtD
Tramadol—Anorexia—Vincristine—lymphatic system cancer	0.00078	0.00078	CcSEcCtD
Tramadol—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000778	0.000778	CcSEcCtD
Tramadol—Body temperature increased—Bleomycin—lymphatic system cancer	0.000776	0.000776	CcSEcCtD
Tramadol—Insomnia—Carmustine—lymphatic system cancer	0.000775	0.000775	CcSEcCtD
Tramadol—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000774	0.000774	CcSEcCtD
Tramadol—Irritability—Methotrexate—lymphatic system cancer	0.000771	0.000771	CcSEcCtD
Tramadol—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00077	0.00077	CcSEcCtD
Tramadol—Paraesthesia—Carmustine—lymphatic system cancer	0.00077	0.00077	CcSEcCtD
Tramadol—Mood swings—Methotrexate—lymphatic system cancer	0.000765	0.000765	CcSEcCtD
Tramadol—Hypotension—Vincristine—lymphatic system cancer	0.000765	0.000765	CcSEcCtD
Tramadol—Dyspnoea—Carmustine—lymphatic system cancer	0.000764	0.000764	CcSEcCtD
Tramadol—Somnolence—Carmustine—lymphatic system cancer	0.000762	0.000762	CcSEcCtD
Tramadol—Anorexia—Mitoxantrone—lymphatic system cancer	0.00076	0.00076	CcSEcCtD
Tramadol—Ataxia—Methotrexate—lymphatic system cancer	0.00076	0.00076	CcSEcCtD
Tramadol—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000746	0.000746	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000745	0.000745	CcSEcCtD
Tramadol—Decreased appetite—Carmustine—lymphatic system cancer	0.000745	0.000745	CcSEcCtD
Tramadol—Hypotension—Mitoxantrone—lymphatic system cancer	0.000745	0.000745	CcSEcCtD
Tramadol—Insomnia—Vincristine—lymphatic system cancer	0.00074	0.00074	CcSEcCtD
Tramadol—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00074	0.00074	CcSEcCtD
Tramadol—Paraesthesia—Vincristine—lymphatic system cancer	0.000735	0.000735	CcSEcCtD
Tramadol—Pain—Carmustine—lymphatic system cancer	0.000733	0.000733	CcSEcCtD
Tramadol—Constipation—Carmustine—lymphatic system cancer	0.000733	0.000733	CcSEcCtD
Tramadol—Breast disorder—Methotrexate—lymphatic system cancer	0.00073	0.00073	CcSEcCtD
Tramadol—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000727	0.000727	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000726	0.000726	CcSEcCtD
Tramadol—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000723	0.000723	CcSEcCtD
Tramadol—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000716	0.000716	CcSEcCtD
Tramadol—Decreased appetite—Vincristine—lymphatic system cancer	0.000711	0.000711	CcSEcCtD
Tramadol—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00071	0.00071	CcSEcCtD
Tramadol—Somnolence—Mitoxantrone—lymphatic system cancer	0.000708	0.000708	CcSEcCtD
Tramadol—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000706	0.000706	CcSEcCtD
Tramadol—Feeling abnormal—Carmustine—lymphatic system cancer	0.000706	0.000706	CcSEcCtD
Tramadol—Fatigue—Vincristine—lymphatic system cancer	0.000705	0.000705	CcSEcCtD
Tramadol—Asthenia—Bleomycin—lymphatic system cancer	0.000705	0.000705	CcSEcCtD
Tramadol—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000701	0.000701	CcSEcCtD
Tramadol—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000701	0.000701	CcSEcCtD
Tramadol—Constipation—Vincristine—lymphatic system cancer	0.0007	0.0007	CcSEcCtD
Tramadol—Pain—Vincristine—lymphatic system cancer	0.0007	0.0007	CcSEcCtD
Tramadol—Asthma—Methotrexate—lymphatic system cancer	0.000698	0.000698	CcSEcCtD
Tramadol—Pruritus—Bleomycin—lymphatic system cancer	0.000695	0.000695	CcSEcCtD
Tramadol—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000693	0.000693	CcSEcCtD
Tramadol—Fatigue—Mitoxantrone—lymphatic system cancer	0.000687	0.000687	CcSEcCtD
Tramadol—Pancreatitis—Methotrexate—lymphatic system cancer	0.000685	0.000685	CcSEcCtD
Tramadol—Pain—Mitoxantrone—lymphatic system cancer	0.000681	0.000681	CcSEcCtD
Tramadol—Constipation—Mitoxantrone—lymphatic system cancer	0.000681	0.000681	CcSEcCtD
Tramadol—Abdominal pain—Carmustine—lymphatic system cancer	0.000678	0.000678	CcSEcCtD
Tramadol—Body temperature increased—Carmustine—lymphatic system cancer	0.000678	0.000678	CcSEcCtD
Tramadol—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000669	0.000669	CcSEcCtD
Tramadol—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000669	0.000669	CcSEcCtD
Tramadol—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000657	0.000657	CcSEcCtD
Tramadol—Dysuria—Methotrexate—lymphatic system cancer	0.000653	0.000653	CcSEcCtD
Tramadol—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000652	0.000652	CcSEcCtD
Tramadol—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000649	0.000649	CcSEcCtD
Tramadol—Abdominal pain—Vincristine—lymphatic system cancer	0.000647	0.000647	CcSEcCtD
Tramadol—Body temperature increased—Vincristine—lymphatic system cancer	0.000647	0.000647	CcSEcCtD
Tramadol—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000643	0.000643	CcSEcCtD
Tramadol—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000637	0.000637	CcSEcCtD
Tramadol—Urticaria—Mitoxantrone—lymphatic system cancer	0.000633	0.000633	CcSEcCtD
Tramadol—Hypersensitivity—Carmustine—lymphatic system cancer	0.000632	0.000632	CcSEcCtD
Tramadol—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00063	0.00063	CcSEcCtD
Tramadol—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00063	0.00063	CcSEcCtD
Tramadol—Pneumonia—Methotrexate—lymphatic system cancer	0.000626	0.000626	CcSEcCtD
Tramadol—Vomiting—Bleomycin—lymphatic system cancer	0.000624	0.000624	CcSEcCtD
Tramadol—Infestation NOS—Methotrexate—lymphatic system cancer	0.000623	0.000623	CcSEcCtD
Tramadol—Infestation—Methotrexate—lymphatic system cancer	0.000623	0.000623	CcSEcCtD
Tramadol—Depression—Methotrexate—lymphatic system cancer	0.000621	0.000621	CcSEcCtD
Tramadol—Rash—Bleomycin—lymphatic system cancer	0.000619	0.000619	CcSEcCtD
Tramadol—Dermatitis—Bleomycin—lymphatic system cancer	0.000619	0.000619	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000617	0.000617	CcSEcCtD
Tramadol—Asthenia—Carmustine—lymphatic system cancer	0.000615	0.000615	CcSEcCtD
Tramadol—Renal failure—Methotrexate—lymphatic system cancer	0.000612	0.000612	CcSEcCtD
Tramadol—Stomatitis—Methotrexate—lymphatic system cancer	0.000607	0.000607	CcSEcCtD
Tramadol—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000605	0.000605	CcSEcCtD
Tramadol—Hypersensitivity—Vincristine—lymphatic system cancer	0.000603	0.000603	CcSEcCtD
Tramadol—Sweating—Methotrexate—lymphatic system cancer	0.000597	0.000597	CcSEcCtD
Tramadol—Haematuria—Methotrexate—lymphatic system cancer	0.000594	0.000594	CcSEcCtD
Tramadol—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000589	0.000589	CcSEcCtD
Tramadol—Epistaxis—Methotrexate—lymphatic system cancer	0.000587	0.000587	CcSEcCtD
Tramadol—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000587	0.000587	CcSEcCtD
Tramadol—Asthenia—Vincristine—lymphatic system cancer	0.000587	0.000587	CcSEcCtD
Tramadol—Diarrhoea—Carmustine—lymphatic system cancer	0.000586	0.000586	CcSEcCtD
Tramadol—Nausea—Bleomycin—lymphatic system cancer	0.000583	0.000583	CcSEcCtD
Tramadol—Asthenia—Mitoxantrone—lymphatic system cancer	0.000572	0.000572	CcSEcCtD
Tramadol—Dizziness—Carmustine—lymphatic system cancer	0.000567	0.000567	CcSEcCtD
Tramadol—Haemoglobin—Methotrexate—lymphatic system cancer	0.000562	0.000562	CcSEcCtD
Tramadol—Diarrhoea—Vincristine—lymphatic system cancer	0.00056	0.00056	CcSEcCtD
Tramadol—Hepatitis—Methotrexate—lymphatic system cancer	0.000559	0.000559	CcSEcCtD
Tramadol—Haemorrhage—Methotrexate—lymphatic system cancer	0.000559	0.000559	CcSEcCtD
Tramadol—Pharyngitis—Methotrexate—lymphatic system cancer	0.000555	0.000555	CcSEcCtD
Tramadol—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000552	0.000552	CcSEcCtD
Tramadol—Urethral disorder—Methotrexate—lymphatic system cancer	0.000548	0.000548	CcSEcCtD
Tramadol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000545	0.000545	CcSEcCtD
Tramadol—Vomiting—Carmustine—lymphatic system cancer	0.000545	0.000545	CcSEcCtD
Tramadol—Dizziness—Vincristine—lymphatic system cancer	0.000541	0.000541	CcSEcCtD
Tramadol—Rash—Carmustine—lymphatic system cancer	0.00054	0.00054	CcSEcCtD
Tramadol—Dermatitis—Carmustine—lymphatic system cancer	0.00054	0.00054	CcSEcCtD
Tramadol—Visual impairment—Methotrexate—lymphatic system cancer	0.000539	0.000539	CcSEcCtD
Tramadol—Headache—Carmustine—lymphatic system cancer	0.000537	0.000537	CcSEcCtD
Tramadol—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000528	0.000528	CcSEcCtD
Tramadol—Eye disorder—Methotrexate—lymphatic system cancer	0.000522	0.000522	CcSEcCtD
Tramadol—Tinnitus—Methotrexate—lymphatic system cancer	0.000521	0.000521	CcSEcCtD
Tramadol—Vomiting—Vincristine—lymphatic system cancer	0.00052	0.00052	CcSEcCtD
Tramadol—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000519	0.000519	CcSEcCtD
Tramadol—Rash—Vincristine—lymphatic system cancer	0.000516	0.000516	CcSEcCtD
Tramadol—Dermatitis—Vincristine—lymphatic system cancer	0.000515	0.000515	CcSEcCtD
Tramadol—Headache—Vincristine—lymphatic system cancer	0.000513	0.000513	CcSEcCtD
Tramadol—Nausea—Carmustine—lymphatic system cancer	0.000509	0.000509	CcSEcCtD
Tramadol—Angiopathy—Methotrexate—lymphatic system cancer	0.000507	0.000507	CcSEcCtD
Tramadol—Vomiting—Mitoxantrone—lymphatic system cancer	0.000507	0.000507	CcSEcCtD
Tramadol—Immune system disorder—Methotrexate—lymphatic system cancer	0.000505	0.000505	CcSEcCtD
Tramadol—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000504	0.000504	CcSEcCtD
Tramadol—Rash—Mitoxantrone—lymphatic system cancer	0.000502	0.000502	CcSEcCtD
Tramadol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000502	0.000502	CcSEcCtD
Tramadol—Chills—Methotrexate—lymphatic system cancer	0.000501	0.000501	CcSEcCtD
Tramadol—Headache—Mitoxantrone—lymphatic system cancer	0.000499	0.000499	CcSEcCtD
Tramadol—Mental disorder—Methotrexate—lymphatic system cancer	0.00049	0.00049	CcSEcCtD
Tramadol—Erythema—Methotrexate—lymphatic system cancer	0.000486	0.000486	CcSEcCtD
Tramadol—Malnutrition—Methotrexate—lymphatic system cancer	0.000486	0.000486	CcSEcCtD
Tramadol—Nausea—Vincristine—lymphatic system cancer	0.000486	0.000486	CcSEcCtD
Tramadol—Dysgeusia—Methotrexate—lymphatic system cancer	0.000476	0.000476	CcSEcCtD
Tramadol—Nausea—Mitoxantrone—lymphatic system cancer	0.000473	0.000473	CcSEcCtD
Tramadol—Back pain—Methotrexate—lymphatic system cancer	0.000471	0.000471	CcSEcCtD
Tramadol—Vision blurred—Methotrexate—lymphatic system cancer	0.000458	0.000458	CcSEcCtD
Tramadol—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000451	0.000451	CcSEcCtD
Tramadol—Anaemia—Methotrexate—lymphatic system cancer	0.00045	0.00045	CcSEcCtD
Tramadol—Malaise—Methotrexate—lymphatic system cancer	0.000439	0.000439	CcSEcCtD
Tramadol—Vertigo—Methotrexate—lymphatic system cancer	0.000437	0.000437	CcSEcCtD
Tramadol—Cough—Methotrexate—lymphatic system cancer	0.000425	0.000425	CcSEcCtD
Tramadol—Convulsion—Methotrexate—lymphatic system cancer	0.000421	0.000421	CcSEcCtD
Tramadol—Myalgia—Methotrexate—lymphatic system cancer	0.000414	0.000414	CcSEcCtD
Tramadol—Arthralgia—Methotrexate—lymphatic system cancer	0.000414	0.000414	CcSEcCtD
Tramadol—Chest pain—Methotrexate—lymphatic system cancer	0.000414	0.000414	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000411	0.000411	CcSEcCtD
Tramadol—Discomfort—Methotrexate—lymphatic system cancer	0.000409	0.000409	CcSEcCtD
Tramadol—Confusional state—Methotrexate—lymphatic system cancer	0.0004	0.0004	CcSEcCtD
Tramadol—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000397	0.000397	CcSEcCtD
Tramadol—Infection—Methotrexate—lymphatic system cancer	0.000394	0.000394	CcSEcCtD
Tramadol—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000389	0.000389	CcSEcCtD
Tramadol—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000389	0.000389	CcSEcCtD
Tramadol—Skin disorder—Methotrexate—lymphatic system cancer	0.000386	0.000386	CcSEcCtD
Tramadol—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000384	0.000384	CcSEcCtD
Tramadol—Anorexia—Methotrexate—lymphatic system cancer	0.000378	0.000378	CcSEcCtD
Tramadol—Hypotension—Methotrexate—lymphatic system cancer	0.000371	0.000371	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000362	0.000362	CcSEcCtD
Tramadol—Insomnia—Methotrexate—lymphatic system cancer	0.000359	0.000359	CcSEcCtD
Tramadol—Paraesthesia—Methotrexate—lymphatic system cancer	0.000357	0.000357	CcSEcCtD
Tramadol—Dyspnoea—Methotrexate—lymphatic system cancer	0.000354	0.000354	CcSEcCtD
Tramadol—Somnolence—Methotrexate—lymphatic system cancer	0.000353	0.000353	CcSEcCtD
Tramadol—Dyspepsia—Methotrexate—lymphatic system cancer	0.000349	0.000349	CcSEcCtD
Tramadol—Decreased appetite—Methotrexate—lymphatic system cancer	0.000345	0.000345	CcSEcCtD
Tramadol—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000343	0.000343	CcSEcCtD
Tramadol—Fatigue—Methotrexate—lymphatic system cancer	0.000342	0.000342	CcSEcCtD
Tramadol—Pain—Methotrexate—lymphatic system cancer	0.00034	0.00034	CcSEcCtD
Tramadol—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000327	0.000327	CcSEcCtD
Tramadol—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000325	0.000325	CcSEcCtD
Tramadol—Urticaria—Methotrexate—lymphatic system cancer	0.000315	0.000315	CcSEcCtD
Tramadol—Abdominal pain—Methotrexate—lymphatic system cancer	0.000314	0.000314	CcSEcCtD
Tramadol—Body temperature increased—Methotrexate—lymphatic system cancer	0.000314	0.000314	CcSEcCtD
Tramadol—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000293	0.000293	CcSEcCtD
Tramadol—Asthenia—Methotrexate—lymphatic system cancer	0.000285	0.000285	CcSEcCtD
Tramadol—Pruritus—Methotrexate—lymphatic system cancer	0.000281	0.000281	CcSEcCtD
Tramadol—Diarrhoea—Methotrexate—lymphatic system cancer	0.000272	0.000272	CcSEcCtD
Tramadol—Dizziness—Methotrexate—lymphatic system cancer	0.000263	0.000263	CcSEcCtD
Tramadol—Vomiting—Methotrexate—lymphatic system cancer	0.000252	0.000252	CcSEcCtD
Tramadol—Rash—Methotrexate—lymphatic system cancer	0.00025	0.00025	CcSEcCtD
Tramadol—Dermatitis—Methotrexate—lymphatic system cancer	0.00025	0.00025	CcSEcCtD
Tramadol—Headache—Methotrexate—lymphatic system cancer	0.000249	0.000249	CcSEcCtD
Tramadol—Nausea—Methotrexate—lymphatic system cancer	0.000236	0.000236	CcSEcCtD
